"Considered the “Headquarters” of Minnesota Eye Consultants, our Bloomington location offers a wide array of services to our patients in the metro area. We proudly perform Cataract Surgery, Glaucoma treatments, LASIK, and more out of our Ambulatory Surgery Center (ASC) and our custom Laser Suite."

During the past decade, Minnesota Eye Consultants conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 11 clinical trials were completed, i.e. on average, 73.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 8 clinical trials were completed. i.e. 160% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Minnesota Eye Consultants" #1 sponsor was "Topcon Medical Systems, Inc." with 3 trials, followed by "InnFocus Inc." with 2 trials sponsored, "Kala Pharmaceuticals, Inc." with 2 trials sponsored, "Lux Biosciences, Inc." with 2 trials sponsored and "MicroOptx" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Minnesota Eye Consultants" #1 collaborator was "National Eye Institute (NEI)" with 2 trials as a collaborator, "HumanOptics AG" with 1 trials as a collaborator, "Jaeb Center for Health Research" with 1 trials as a collaborator, "NovaBay Pharmaceuticals, Inc." with 1 trials as a collaborator and "Science in Vision" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Minnesota Eye Consultants" are "Dry Eye" (3 trials), "Glaucoma" (3 trials), "Glaucoma, Open-Angle" (3 trials), "Cataract" (2 trials) and "Ectasia" (2 trials). Many other conditions were trialed in "Minnesota Eye Consultants" in a lesser frequency.

Most popular intervention types in "Minnesota Eye Consultants" are "Device" (13 trials), "Drug" (13 trials), "Other" (4 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Riboflavin" (3 trials), "LX201" (2 trials), "OMNI® Surgical System" (2 trials) and "PVP-I 0.6%" (2 trials). Other intervention names were less common.

The vast majority of trials in "Minnesota Eye Consultants" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Minnesota Eye Consultants". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Minnesota Eye Consultants, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Minnesota Eye Consultants, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 7 trials that are defined as “Not Applicable".